Human embryonic stem cell derived mesenchymal stem cells (Tongji Hospital)

N/A

Report date: 2023/01/12 16:08:24

Base Information

Drug NameHuman embryonic stem cell derived mesenchymal stem cells (Tongji Hospital)
Drug Alias Name人胚胎干细胞来源的间充质干细胞
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMeniscus InjuriesKnee Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTongji Hospital
China Registration ClassN/A

Develop Information

Active CompaniesTongji Hospital
Inactive CompaniesN/A
Active IndicationsKnee Injuries
Inactive IndicationsMeniscus Injuries

Other Information

ATC CodeN/A
Related LinksN/A